231 related articles for article (PubMed ID: 12109780)
21. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
23. Toward a reduction of the global burden of cervical cancer.
Rohan TE; Burk RD; Franco EL
Am J Obstet Gynecol; 2003 Oct; 189(4 Suppl):S37-9. PubMed ID: 14586318
[TBL] [Abstract][Full Text] [Related]
24. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
Schiffman M; Kjaer SK
J Natl Cancer Inst Monogr; 2003; (31):14-9. PubMed ID: 12807940
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus (HPV) infections of the female genital tract and their associations with intraepithelial neoplasia and squamous cell carcinoma.
Syrjänen KJ
Pathol Annu; 1986; 21 Pt 1():53-89. PubMed ID: 3001622
[TBL] [Abstract][Full Text] [Related]
26. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
27. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer--what role for human papillomavirus?
Garland SM; Faulkner-Jones BE; Fortune DW; Quinn MA
Med J Aust; 1992 Feb; 156(3):204-12. PubMed ID: 1312213
[TBL] [Abstract][Full Text] [Related]
29. Genital HPV: links to cervical cancer, treatment, and prevention.
Perez LA
Clin Lab Sci; 2001; 14(3):183-6; quiz 193. PubMed ID: 11517629
[TBL] [Abstract][Full Text] [Related]
30. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus, cervical cancer, and the vaccines.
Tovar JM; Bazaldua OV; Vargas L; Reile E
Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology of genital human papillomavirus infection.
Trottier H; Franco EL
Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the relationship between clinicopathological features and human papillomavirus types in female lower genital tract carcinoma].
Guo L; Liu T; Li C; Li M
Zhonghua Bing Li Xue Za Zhi; 2001 Aug; 30(4):245-8. PubMed ID: 11758209
[TBL] [Abstract][Full Text] [Related]
34. Genital human papillomavirus infection.
Lowy DR; Kirnbauer R; Schiller JT
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2436-40. PubMed ID: 8146136
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus: disease and laboratory diagnosis.
Swygart C
Br J Biomed Sci; 1997 Dec; 54(4):299-303. PubMed ID: 9624741
[TBL] [Abstract][Full Text] [Related]
36. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus: the burden of infection.
Wiley D; Masongsong E
Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S3-14. PubMed ID: 16729902
[TBL] [Abstract][Full Text] [Related]
38. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus and human disease.
Beutner KR; Tyring S
Am J Med; 1997 May; 102(5A):9-15. PubMed ID: 9217657
[TBL] [Abstract][Full Text] [Related]
40. How will HPV vaccines affect cervical cancer?
Roden R; Wu TC
Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
